Michael H. Davidson is Chief Executive Officer of NewAmsterdam Pharma Company NV.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
3/A
NewAmsterdam Pharma Co N.V.
25 Jan 24
4
NewAmsterdam Pharma Co N.V.
3 Jan 24
3
NewAmsterdam Pharma Co N.V.
29 Dec 23
4
TENAX THERAPEUTICS, INC.
10 Jun 22
4
CALADRIUS BIOSCIENCES, INC.
12 Jan 22
4
TENAX THERAPEUTICS, INC.
15 Jun 21
3
TENAX THERAPEUTICS, INC.
15 Jun 21
4
CALADRIUS BIOSCIENCES, INC.
12 Jan 21
4
CALADRIUS BIOSCIENCES, INC.
10 Sep 20
4
CALADRIUS BIOSCIENCES, INC.
12 Aug 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jan 24 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 11.17 | 1,039,939 | 11.62 mm | 1,039,939 |